PAC-G31P

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePAC-G31P
Drug Alias NameIL-8(3-73)K11R/G31PCXCR1/CXCR2 antagonist (Saskatchewan)G31PPAC-G31P
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsNeutrophil infiltration inhibitorsC-X-C motif chemokine receptor 2 antagonists
TargetsC-X-C motif chemokine receptor 2C-X-C motif chemokine receptor 1
Therapy Area/IndicationsInflammationRespiratory Distress Syndrome, AdultRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Saskatchewan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIL Therapeutics IncPacgen Life ScienceUniversity Of Saskatchewan
Active IndicationsN/A
Inactive IndicationsInflammationRespiratory Distress Syndrome, AdultRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A